Literature DB >> 11815741

Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.

I J Platz1, M Binder, A Marxer, G Lischka, P Valent, H J Bühring.   

Abstract

BACKGROUND: Bee and wasp venoms are potent allergens capable of inducing severe clinical reactions. To detect immediate-type hypersensitivity to these allergens, a rapid in vitro test was developed that relies on the upregulation of ecto-nucleotide pyrophosphatase/phosphodiesterase 3 (E-NPP3) on activated basophils.
METHODS: Blood basophils of 13 healthy donors and 22 patients allergic to bee or wasp venom were analyzed for E-NPP3 (CD203c) expression using monoclonal antibody 97A6. Basophils were analyzed by flow cytometry after activation with anti-IgE antibody or allergen. Venom-induced E-NPP3 upregulation on basophils was compared with diagnostic parameters, including skin tests and assessment of specific IgE. In selected samples, the increase in E-NPP3 expression on activated basophils was compared with histamine release and CD63 upregulation.
RESULTS: In 20/22 patients sensitized to wasp or bee venom, E-NPP3 expression on basophils was upregulated in response to activation by allergen or anti-IgE. The maximum increase in E-NPP3 expression (above ten times of baseline) was achieved after 15 min of stimulation with 1 microg/ml of allergen or anti-IgE antibody. Sensitized individuals who failed to upregulate E-NPP3 in response to IgE receptor cross-linking also failed to induce histamine release and CD63 upregulation.
CONCLUSIONS: Flow cytometric determination of hymenoptera-venom-induced upregulation of E-NPP3 is a novel in vitro test to identify sensitized individuals. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11815741     DOI: 10.1159/000049531

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  [Cellular in-vitro assays. Applicability in daily routine].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

2.  Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2014-03-20       Impact factor: 10.793

3.  Role of basophils in rheumatoid arthritis (Review).

Authors:  Pei Tang; Qiuhua Chen; Qiaofen Lan; Yanwen Chen; Haijuan Yang; Ning An; Haiyan Xiao; Huafeng Liu; Ping Wu; Tong Xie; Qingjun Pan
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

4.  The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives.

Authors:  Radhia Boumiza; Anne-Lise Debard; Guillaume Monneret
Journal:  Clin Mol Allergy       Date:  2005-06-30

Review 5.  Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy.

Authors:  Anuya Paranjape; Mindy Tsai; Kaori Mukai; Ramona A Hoh; Shilpa A Joshi; R Sharon Chinthrajah; Kari C Nadeau; Scott D Boyd; Stephen J Galli
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

6.  Differential response of human basophil activation markers: a multi-parameter flow cytometry approach.

Authors:  Salvatore Chirumbolo; Antonio Vella; Riccardo Ortolani; Marzia De Gironcoli; Pietro Solero; Giuseppe Tridente; Paolo Bellavite
Journal:  Clin Mol Allergy       Date:  2008-10-16

7.  Decreased expression of CD200R3 on mouse basophils as a novel marker for IgG1-mediated anaphylaxis.

Authors:  Hiroshi Iwamoto; Takeshi Matsubara; Yuki Nakazato; Kazuyoshi Namba; Yasuhiro Takeda
Journal:  Immun Inflamm Dis       Date:  2015-06-16

8.  Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone.

Authors:  Tahia D Fernández; Adriana Ariza; Francisca Palomares; María I Montañez; María Salas; Angela Martín-Serrano; Rubén Fernández; Arturo Ruiz; Miguel Blanca; Cristobalina Mayorga; María J Torres
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.